Voice of Customer
Nationwide VoC project
This project aims to integrate the voices of clinical experts—including ObGyns, Minimally Invasive Gynecologic Surgeons (MIGS), and Reproductive Endocrinologists (REIs)—together with the lived experiences of patients diagnosed with endometriosis, to strategically inform the development of a novel therapeutic option by Sur180 Therapeutics.
The methodology consists of a Voice of Customer (VoC) Analysis, conducted as part of Specific Aim 3 of an NIH-funded Phase II preclinical study NIH. The primary objective is to gather expert insights on the effectiveness, limitations, and opportunities for improvement of current and emerging endometriosis treatments, generating practical evidence to support internal decision-making, product development, and stakeholder communications (including potential investors). Expected outcomes include actionable, patient-centered insights that accelerate and optimize Sur180’s therapeutic strategy.
This nationwide VoC project is conducted by Santiago Solutions Group (SSG), a California-based firm with extensive experience in qualitative and quantitative research, predictive modeling, and advanced analytics. In this Phase 1 effort, SSG engages physicians and patients, our product's primary customers, to better understand unmet needs, treatment experiences, clinical decision-making factors, and reactions to Sur180’s emerging therapeutic approach, while ensuring ethical standards, secure data management, and IRB-approved protocols.
